Prevention of Events With Angiotensin-Converting Enzyme Inhibitor Therapy (PEACE)

Trial Profile

Prevention of Events With Angiotensin-Converting Enzyme Inhibitor Therapy (PEACE)

Completed
Phase of Trial: Phase III

Latest Information Update: 18 Apr 2016

At a glance

  • Drugs Trandolapril (Primary)
  • Indications Coronary artery disease; Sudden death
  • Focus Biomarker; Pharmacodynamics; Therapeutic Use
  • Acronyms PEACE
  • Most Recent Events

    • 16 Dec 2011 Biomarker substudy results published in Circulation.
    • 18 Sep 2007 The expected completion date for this trial is now 1 Jun 2005.
    • 22 Oct 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top